Clinical Trials Browser

Phase 1 × Ganglioneuroblastoma × 90 days × Clear all

NCT02311621 2026-05-19

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

Phase 1 Active not recruiting

Neuroblastoma, Ganglioneuroblastoma